Clinical Trials in Georgia

Showing 4441-4460 of 19,050 trials

PTG-300 in Subjects With Hereditary Hemochromatosis

NCT04202965

This study will be conducted at multiple sites and every patient will get treated with PTG-300. The objective of the study is to assess the effect of PTG-300 in treating adult hereditary hemochromatosis patients.

Hereditary Hemochromatosis

Protagonist Therapeutics, Inc.16 participantsStarted Mar 2020

Fayetteville, Georgia, United States • Bethesda, Maryland, United States • Charlotte, North Carolina, United States +8 more locations

RECRUITINGNA65 miles

PRIMARY Ancillary Substudy

NCT07103733

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.

Mitral Valve ProlapseLeft Ventricular FibrosisVentricular Arrhythmias

Annetine Gelijns250 participantsStarted Oct 2023

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +22 more locations

PTG-300 in Subjects With Hereditary Hemochromatosis

PRIMARY Ancillary Substudy

Find Trials by Condition in Georgia

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Breathwork Intervention for Posttraumatic Stress

ARrest RESpiraTory Failure From PNEUMONIA

Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)